News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,194 Results
Type
Article (41772)
Company Profile (291)
Press Release (694119)
Multimedia
Podcasts (85)
Webinars (21)
Section
Business (208692)
Career Advice (2094)
Deals (36115)
Drug Delivery (112)
Drug Development (81739)
Employer Resources (174)
FDA (16727)
Job Trends (15297)
News (352022)
Policy (33180)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2641)
Accelerated approval (33)
Adcomms (24)
Allergies (144)
Alliances (51058)
ALS (169)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (315)
Approvals (16996)
Artificial intelligence (544)
Autoimmune disease (159)
Automation (39)
Bankruptcy (363)
Best Places to Work (11935)
BIOSECURE Act (21)
Biosimilars (192)
Biotechnology (186)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (647)
Cancer (4858)
Cardiovascular disease (403)
Career advice (1769)
Career pathing (36)
CAR-T (285)
CDC (44)
Celiac Disease (2)
Cell therapy (750)
Cervical cancer (36)
Clinical research (69844)
Collaboration (1765)
Company closure (4)
Compensation (1168)
Complete response letters (58)
COVID-19 (2750)
CRISPR (94)
C-suite (869)
Cystic fibrosis (145)
Data (6269)
Decentralized trials (2)
Denatured (29)
Depression (134)
Diabetes (502)
Diagnostics (6893)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (261)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (91233)
Editorial (58)
Employer branding (21)
Employer resources (153)
Events (119817)
Executive appointments (1010)
FDA (19903)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1505)
Gene editing (201)
Generative AI (45)
Gene therapy (607)
GLP-1 (977)
Government (4726)
Grass and pollen (6)
Guidances (385)
Healthcare (19388)
HIV (61)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (253)
Immuno-oncology (59)
Indications (113)
Infectious disease (3025)
Inflammatory bowel disease (192)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (252)
Interviews (329)
IPO (16856)
IRA (50)
Job creations (3704)
Job search strategy (1472)
JPM (57)
Kidney cancer (16)
Labor market (87)
Layoffs (547)
Leadership (32)
Legal (8043)
Liver cancer (91)
Longevity (14)
Lung cancer (653)
Lymphoma (380)
Machine learning (43)
Management (59)
Manufacturing (811)
MASH (164)
Medical device (14295)
Medtech (14350)
Mergers & acquisitions (20353)
Metabolic disorders (1274)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (317)
Neuropsychiatric disorders (88)
Neuroscience (2922)
Neurotech (1)
NextGen: Class of 2026 (6769)
Non-profit (4602)
Now hiring (67)
Obesity (599)
Opinion (265)
Ovarian cancer (166)
Pain (204)
Pancreatic cancer (230)
Parkinson's disease (283)
Partnered (35)
Patents (503)
Patient recruitment (495)
Peanut (57)
People (60095)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21770)
Phase 2 (30728)
Phase 3 (22909)
Pipeline (5385)
Policy (286)
Postmarket research (2573)
Preclinical (9243)
Press Release (65)
Prostate cancer (241)
Psychedelics (48)
Radiopharmaceuticals (285)
Rare diseases (846)
Real estate (6120)
Recruiting (70)
Regulatory (24863)
Reports (53)
Research institute (2461)
Resumes & cover letters (365)
Rett syndrome (27)
RNA editing (18)
RSV (78)
Schizophrenia (149)
Series A (244)
Series B (196)
Service/supplier (15)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (160)
Sponsored (45)
Startups (3680)
State (2)
Stomach cancer (17)
Supply chain (108)
Tariffs (84)
The Weekly (54)
Vaccines (1020)
Venture capital (90)
Weight loss (383)
Women's health (92)
Worklife (19)
Date
Today (127)
Last 7 days (561)
Last 30 days (2195)
Last 365 days (30359)
2026 (3667)
2025 (30677)
2024 (35777)
2023 (40670)
2022 (51851)
2021 (56490)
2020 (55155)
2019 (47966)
2018 (36168)
2017 (32809)
2016 (32289)
2015 (38345)
2014 (31991)
2013 (26987)
2012 (29242)
2011 (29878)
2010 (27875)
Location
Africa (759)
Alabama (85)
Alaska (7)
Arizona (311)
Arkansas (13)
Asia (40171)
Australia (6520)
California (11415)
Canada (3319)
China (1115)
Colorado (484)
Connecticut (484)
Delaware (343)
Europe (87921)
Florida (1705)
Georgia (372)
Hawaii (3)
Idaho (66)
Illinois (892)
India (68)
Indiana (532)
Iowa (23)
Japan (436)
Kansas (129)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1395)
Massachusetts (8206)
Michigan (349)
Minnesota (650)
Mississippi (6)
Missouri (139)
Montana (32)
Nebraska (28)
Nevada (126)
New Hampshire (79)
New Jersey (3050)
New Mexico (30)
New York (3018)
North Carolina (1510)
North Dakota (9)
Northern California (5566)
Ohio (351)
Oklahoma (23)
Oregon (41)
Pennsylvania (2297)
Puerto Rico (24)
Rhode Island (50)
South America (1150)
South Carolina (68)
South Dakota (1)
Southern California (4452)
Tennessee (177)
Texas (1785)
United States (40712)
Utah (345)
Vermont (1)
Virginia (268)
Washington D.C. (83)
Washington State (929)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
736,194 Results for "chf solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE® Rollout
September 23, 2025
·
6 min read
Press Releases
Indivi Secures CHF15 Million Investment to Accelerate the Discovery of Treatment Response Biomarkers in Neuroscience Drug Development, Targeting Alzheimer’s Disease
November 12, 2025
·
2 min read
Press Releases
arcoris bio raises CHF 6.3 million seed round to advance next-generation biomarker technology for digital pathology
November 6, 2025
·
2 min read
Press Releases
Oculis Upsized Loan Facility to Access up to CHF 100 million
August 1, 2025
·
4 min read
Press Releases
Curatis Expands Distribution Business With Phoenix Labs with up to CHF 5m Additional Annual Revenues
September 5, 2025
·
2 min read
Press Releases
CUTISS closes CHF 56M Series C round and signs agreement with leading EU burn center
September 10, 2025
·
2 min read
Press Releases
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
January 8, 2026
·
6 min read
Memo Therapeutics increases Series C financing to CHF 45 million
Memo Therapeutics AG announces that it has successfully raised CHF 20 million as part of an extension of its Series C financing, bringing the total amount raised in the funding round to CHF 45 million.
May 7, 2024
·
5 min read
Press Releases
Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Conce
- Funding combines equity investment and convertible loan - Focus on best-in-class, clinical-stage peanut allergen neutralizing antibody - Further potential for developing Mabylon’s discovery and pre-clinical pipeline programs - Dr. Thomas Hecht has joined Board of Directors
August 13, 2025
·
1 min read
Press Releases
Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs
June 30, 2025
·
3 min read
1 of 73,620
Next
